{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-071960","form_type":"8-K","ticker":"AXSM","cik":"0001579428","company_name":"Axsome Therapeutics, Inc.","filed_at":"2024-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.056374+00:00","generated_at":"2026-06-01T05:02:59.861571+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Axsome Therapeutics stockholders elect directors, ratify auditor, approve executive compensation at 2024 annual meeting","bullets":["Re-elected Herriot Tabuteau (33.3M for, 0.5M withheld) and Mark Coleman (27.1M for, 6.7M withheld) as Class III directors.","Ratified Deloitte & Touche as independent auditor for FY2024 with 39.1M for, 0.15M against.","Advisory vote approved named executive officer compensation: 32.9M for, 0.87M against.","Approximately 84% of eligible shares (39.9M of 47.5M) were represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-071960","json":"https://secwatch.observer/filing/0000950170-24-071960.json","markdown":"https://secwatch.observer/filing/0000950170-24-071960.md","text":"https://secwatch.observer/filing/0000950170-24-071960.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1579428/000095017024071960/0000950170-24-071960-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1579428/000095017024071960/axsm-20240607.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:02:59.861571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}